Surgalign Holdings (Nasdaq: SRGA) has announced its agreement to acquire Holo Surgical Inc. for up to $125 million. This includes $42 million payable at closing and potential milestone payments. The acquisition centers around Holo Surgical’s ARAI™ platform, aimed at enhancing spine surgery with augmented reality and AI capabilities. The deal is expected to close in Q4 2020. Surgalign anticipates that integrating this technology will drive new revenue streams and improve patient outcomes.
Surgalign Holdings, Inc. (SRGA) announced the acquisition of Holo Surgical Inc. for up to $125 million, which includes $42 million payable at closing and up to $83 million in future milestone payments. This strategic move aims to enhance Spine surgery through Holo Surgical’s Augmented Reality and AI platform, enabling better surgical outcomes. The deal is expected to close in Q4 2020, subject to customary conditions. The acquisition reinforces Surgalign's commitment to digital surgery, providing differentiated technology and potential for new revenue streams.
Surgalign Holdings, a global spine company listed on Nasdaq as SRGA, will participate in the Sidoti Small Cap Virtual Conference on September 24, 2020, presenting at 4:00 p.m. ET. A live audio webcast will be accessible on the company's investor relations website, with a replay available for 90 days post-conference. Surgalign focuses on advancing spine surgery and improving patient outcomes through innovation and quality products, operating in over 50 countries and boasting strong distribution networks.
Surgalign Holdings, Inc. (Nasdaq: SRGA) will present at the Cantor Fitzgerald Virtual Global Healthcare Conference on September 17, 2020, at 2:40 p.m. Eastern Time. The presentation will be accessible via livestream on the company's investor relations webpage. A replay will be available for approximately 90 days post-event. Surgalign, headquartered in Deerfield, IL, specializes in spine surgery solutions, emphasizing innovation and superior outcomes across more than 50 countries. The company aims to enhance patient care through high-quality spine technology.
Surgalign Holdings, Inc. (Nasdaq: SRGA) announced the appointment of Douglas S. Bireley as Executive Vice President, Marketing and Research & Development, effective August 17, 2020. Bireley brings over 20 years of spine industry experience, previously serving as senior director at Johnson & Johnson. His expertise in marketing, product development, and international operations is expected to enhance Surgalign's marketing and R&D competencies, driving innovation and improving patient outcomes. This strategic appointment is seen as a critical step in building a top-tier executive leadership team.
Surgalign Holdings, Inc. (Nasdaq: SRGA) announced its second quarter 2020 financial results will be released on August 4, 2020, before market open. A conference call will follow at 9:00 a.m. ET, accessible at (877) 383-7419 (U.S.) or (760) 666-3754 (International), using conference ID 8591446. The call will also be available via webcast on Surgalign’s investor website. As a global spine technology company, Surgalign focuses on innovative solutions to enhance surgical outcomes and patient lives, distributing its products in over 50 countries.